HEADER OXIDOREDUCTASE 10-MAR-08 2VQ3 TITLE CRYSTAL STRUCTURE OF THE MEMBRANE PROXIMAL OXIDOREDUCTASE DOMAIN OF TITLE 2 HUMAN STEAP3, THE DOMINANT FERRIC REDUCTASE OF THE ERYTHROID TITLE 3 TRANSFERRIN CYCLE COMPND MOL_ID: 1; COMPND 2 MOLECULE: METALLOREDUCTASE STEAP3; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: NADPH/FLAVIN DEPENDENT OXIDOREDUCTASE, RESIDUES 1-215; COMPND 5 SYNONYM: STEAP3 DIMER WITH NADPH, SIX-TRANSMEMBRANE EPITHELIAL COMPND 6 ANTIGEN OF PROSTATE 3, TUMOR SUPPRESSOR-ACTIVATED PATHWAY PROTEIN 6, COMPND 7 HTSAP6, PHYDE, HPHYDE, DUDULIN-2; COMPND 8 EC: 1.16.1.2, 1.16.1.-; COMPND 9 ENGINEERED: YES; COMPND 10 OTHER_DETAILS: RESIDUES 1-215 CLONED, NADPH BOUND SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 ORGAN: KIDNEY; SOURCE 6 TISSUE: RENAL CELL ADENOCARCINOMA; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 10 EXPRESSION_SYSTEM_VARIANT: RIL; SOURCE 11 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 12 EXPRESSION_SYSTEM_PLASMID: PDEST14 KEYWDS METAL-BINDING, TRANSMEMBRANE, ROSSMANN FOLD, TRANSPORT, CELL CYCLE, KEYWDS 2 TRANSFERRIN, FLAVOPROTEIN, ALTERNATIVE SPLICING, TRANSFERRIN KEYWDS 3 RECEPTOR, FERRIREDUCTASE, FERRIC-REDUCTASE, IRON TRANSPORT, KEYWDS 4 PHOSPHOPROTEIN, OXIDOREDUCTASE, STEAP3, COPPER, MEMBRANE, ENDOSOME, KEYWDS 5 APOPTOSIS, TF, NAD, TFR, FAD, FNO, NADP, TFR1, IRON, STEAP, KEYWDS 6 POLYMORPHISM, GLYCOPROTEIN, ION TRANSPORT, DINUCLEOTIDE-BINDING KEYWDS 7 DOMAIN EXPDTA X-RAY DIFFRACTION AUTHOR A.K.SENDAMARAI,R.S.OHGAMI,M.D.FLEMING,C.M.LAWRENCE REVDAT 5 31-JAN-24 2VQ3 1 REMARK REVDAT 4 02-NOV-22 2VQ3 1 REMARK REVDAT 3 24-FEB-09 2VQ3 1 VERSN REVDAT 2 03-JUN-08 2VQ3 1 JRNL REVDAT 1 06-MAY-08 2VQ3 0 JRNL AUTH A.K.SENDAMARAI,R.S.OHGAMI,M.D.FLEMING,C.M.LAWRENCE JRNL TITL STRUCTURE OF THE MEMBRANE PROXIMAL OXIDOREDUCTASE DOMAIN OF JRNL TITL 2 HUMAN STEAP3, THE DOMINANT FERRIREDUCTASE OF THE ERYTHROID JRNL TITL 3 TRANSFERRIN CYCLE JRNL REF PROC.NATL.ACAD.SCI.USA V. 105 7410 2008 JRNL REFN ISSN 0027-8424 JRNL PMID 18495927 JRNL DOI 10.1073/PNAS.0801318105 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH R.S.OHGAMI,D.R.CAMPAGNA,E.L.GREER,B.ANTIOCHOS,A.MCDONALD, REMARK 1 AUTH 2 J.CHEN,J.J.SHARP,Y.FUJIWARA,J.E.BARKER,M.D.FLEMING REMARK 1 TITL IDENTIFICATION OF A FERRIREDUCTASE REQUIRED FOR EFFICIENT REMARK 1 TITL 2 TRANSFERRIN-DEPENDENT IRON UPTAKE IN ERYTHROID CELLS REMARK 1 REF NAT.GENET. V. 37 1264 2005 REMARK 1 REFN ISSN 1061-4036 REMARK 1 PMID 16227996 REMARK 1 DOI 10.1038/NG1658 REMARK 1 REFERENCE 2 REMARK 1 AUTH R.S.OHGAMI,D.R.CAMPAGNA,B.ANTIOCHOS,E.B.WOOD,J.J.SHARP, REMARK 1 AUTH 2 J.E.BARKER,M.D.FLEMING REMARK 1 TITL NM1054, A SPONTANEOUS, RECESSIVE, HYPOCHROMIC, MICROCYTIC REMARK 1 TITL 2 ANEMIA MUTATION IN THE MOUSE REMARK 1 REF BLOOD V. 106 3625 2005 REMARK 1 REFN ISSN 0006-4971 REMARK 1 PMID 15994289 REMARK 1 DOI 10.1182/BLOOD-2005-01-0379 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 3 NUMBER OF REFLECTIONS : 23736 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.199 REMARK 3 R VALUE (WORKING SET) : 0.197 REMARK 3 FREE R VALUE : 0.236 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.200 REMARK 3 FREE R VALUE TEST SET COUNT : 1293 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.05 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1620 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2020 REMARK 3 BIN FREE R VALUE SET COUNT : 97 REMARK 3 BIN FREE R VALUE : 0.2920 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2729 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 109 REMARK 3 SOLVENT ATOMS : 125 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 19.31 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.22000 REMARK 3 B22 (A**2) : 1.73000 REMARK 3 B33 (A**2) : -1.95000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.172 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.113 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 7.907 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.951 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.929 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2967 ; 0.015 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 1990 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4055 ; 1.498 ; 2.005 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4852 ; 3.295 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 374 ;38.944 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 119 ;33.631 ;23.613 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 467 ;15.863 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 22 ;20.298 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 457 ; 0.087 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3284 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 578 ; 0.004 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 618 ; 0.237 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 2002 ; 0.241 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1444 ; 0.179 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 1543 ; 0.099 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 143 ; 0.191 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 19 ; 0.277 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 48 ; 0.302 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 8 ; 0.291 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2329 ; 1.531 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2967 ; 1.673 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1278 ; 2.058 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1086 ; 2.925 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. DISORDERED REGION BETWEEN RESIDUES 159 TO 164 HAS REMARK 3 POOR DENSITY FOR SIDE CHAINS. REMARK 4 REMARK 4 2VQ3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 10-MAR-08. REMARK 100 THE DEPOSITION ID IS D_1290035648. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-MAR-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL9-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.1271 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL MONOCHROMATOR REMARK 200 OPTICS : FLAT COLLIMATING MIRROR, DOUBLE REMARK 200 CRYSTAL MONOCHROMATOR, TOROID REMARK 200 FOCUSING MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 27874 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.920 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 5.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.5 REMARK 200 DATA REDUNDANCY : 3.900 REMARK 200 R MERGE (I) : 0.03000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 19.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.92 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.99 REMARK 200 COMPLETENESS FOR SHELL (%) : 85.1 REMARK 200 DATA REDUNDANCY IN SHELL : 3.60 REMARK 200 R MERGE FOR SHELL (I) : 0.27000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: PDB ENTRY 2VNS REMARK 200 REMARK 200 REMARK: RIGID BODY REFINED AND FURTHER REFINE FROM APO- STRUCTURE REMARK 200 2VNS REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.84 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.31 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.01M FECL3, 40-100MM NA3.CITRATE, 4% REMARK 280 V/V JEFFAMINE M600 PH5.6 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 18.84300 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 71.68300 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 33.40600 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 71.68300 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 18.84300 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 33.40600 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 TOTAL BURIED SURFACE AREA: 1760 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19340 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 1.9 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 PRO A 2 REMARK 465 GLU A 3 REMARK 465 GLU A 4 REMARK 465 MET A 5 REMARK 465 ASP A 6 REMARK 465 LYS A 7 REMARK 465 PRO A 8 REMARK 465 LEU A 9 REMARK 465 ILE A 10 REMARK 465 SER A 11 REMARK 465 LEU A 12 REMARK 465 HIS A 13 REMARK 465 LEU A 14 REMARK 465 VAL A 15 REMARK 465 ASP A 16 REMARK 465 SER A 17 REMARK 465 ASP A 18 REMARK 465 SER A 19 REMARK 465 SER A 20 REMARK 465 LEU A 21 REMARK 465 ALA A 22 REMARK 465 LYS A 23 REMARK 465 VAL A 24 REMARK 465 PRO A 25 REMARK 465 ASP A 26 REMARK 465 GLU A 27 REMARK 465 ALA A 28 REMARK 465 PRO A 210 REMARK 465 ALA A 211 REMARK 465 TRP A 212 REMARK 465 LYS A 213 REMARK 465 VAL A 214 REMARK 465 PRO A 215 REMARK 465 MET B 1 REMARK 465 PRO B 2 REMARK 465 GLU B 3 REMARK 465 GLU B 4 REMARK 465 MET B 5 REMARK 465 ASP B 6 REMARK 465 LYS B 7 REMARK 465 PRO B 8 REMARK 465 LEU B 9 REMARK 465 ILE B 10 REMARK 465 SER B 11 REMARK 465 LEU B 12 REMARK 465 HIS B 13 REMARK 465 LEU B 14 REMARK 465 VAL B 15 REMARK 465 ASP B 16 REMARK 465 SER B 17 REMARK 465 ASP B 18 REMARK 465 SER B 19 REMARK 465 SER B 20 REMARK 465 LEU B 21 REMARK 465 ALA B 22 REMARK 465 LYS B 23 REMARK 465 VAL B 24 REMARK 465 PRO B 25 REMARK 465 ASP B 26 REMARK 465 GLU B 27 REMARK 465 ALA B 28 REMARK 465 LEU B 209 REMARK 465 PRO B 210 REMARK 465 ALA B 211 REMARK 465 TRP B 212 REMARK 465 LYS B 213 REMARK 465 VAL B 214 REMARK 465 PRO B 215 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 104 CG OD1 OD2 REMARK 470 LEU A 209 CG CD1 CD2 REMARK 470 LEU B 208 CG CD1 CD2 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 ARG B 63 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 CE MET B 188 O HOH B 458 1.20 REMARK 500 OG SER B 36 O3X NAP B 301 1.86 REMARK 500 NH1 ARG A 46 O MET A 185 2.02 REMARK 500 O2X NAP A 301 O HOH A 401 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OG SER A 82 OG SER B 82 4546 2.04 REMARK 500 NH1 ARG A 59 NH2 ARG B 63 1655 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 THR A 45 C ARG A 46 N -0.217 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 GLY A 161 N - CA - C ANGL. DEV. = -16.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 90 58.10 -99.90 REMARK 500 PHE A 146 2.87 84.62 REMARK 500 LEU A 208 -93.17 -97.67 REMARK 500 ALA B 90 56.65 -98.78 REMARK 500 PHE B 146 4.64 84.37 REMARK 500 ARG B 159 24.46 -73.88 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAP A1210 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAP B1210 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CIT A1211 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2VNS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE MEMBRANE PROXIMAL OXIDOREDUCTASE DOMAIN OF REMARK 900 HUMAN STEAP3, THE DOMINANT FERRIC REDUCTASE OF THE ERYTHROID REMARK 900 TRANSFERRIN CYCLE DBREF 2VQ3 A 1 215 UNP Q658P3 STEA3_HUMAN 1 215 DBREF 2VQ3 B 1 215 UNP Q658P3 STEA3_HUMAN 1 215 SEQRES 1 A 215 MET PRO GLU GLU MET ASP LYS PRO LEU ILE SER LEU HIS SEQRES 2 A 215 LEU VAL ASP SER ASP SER SER LEU ALA LYS VAL PRO ASP SEQRES 3 A 215 GLU ALA PRO LYS VAL GLY ILE LEU GLY SER GLY ASP PHE SEQRES 4 A 215 ALA ARG SER LEU ALA THR ARG LEU VAL GLY SER GLY PHE SEQRES 5 A 215 LYS VAL VAL VAL GLY SER ARG ASN PRO LYS ARG THR ALA SEQRES 6 A 215 ARG LEU PHE PRO SER ALA ALA GLN VAL THR PHE GLN GLU SEQRES 7 A 215 GLU ALA VAL SER SER PRO GLU VAL ILE PHE VAL ALA VAL SEQRES 8 A 215 PHE ARG GLU HIS TYR SER SER LEU CYS SER LEU SER ASP SEQRES 9 A 215 GLN LEU ALA GLY LYS ILE LEU VAL ASP VAL SER ASN PRO SEQRES 10 A 215 THR GLU GLN GLU HIS LEU GLN HIS ARG GLU SER ASN ALA SEQRES 11 A 215 GLU TYR LEU ALA SER LEU PHE PRO THR CYS THR VAL VAL SEQRES 12 A 215 LYS ALA PHE ASN VAL ILE SER ALA TRP THR LEU GLN ALA SEQRES 13 A 215 GLY PRO ARG ASP GLY ASN ARG GLN VAL PRO ILE CYS GLY SEQRES 14 A 215 ASP GLN PRO GLU ALA LYS ARG ALA VAL SER GLU MET ALA SEQRES 15 A 215 LEU ALA MET GLY PHE MET PRO VAL ASP MET GLY SER LEU SEQRES 16 A 215 ALA SER ALA TRP GLU VAL GLU ALA MET PRO LEU ARG LEU SEQRES 17 A 215 LEU PRO ALA TRP LYS VAL PRO SEQRES 1 B 215 MET PRO GLU GLU MET ASP LYS PRO LEU ILE SER LEU HIS SEQRES 2 B 215 LEU VAL ASP SER ASP SER SER LEU ALA LYS VAL PRO ASP SEQRES 3 B 215 GLU ALA PRO LYS VAL GLY ILE LEU GLY SER GLY ASP PHE SEQRES 4 B 215 ALA ARG SER LEU ALA THR ARG LEU VAL GLY SER GLY PHE SEQRES 5 B 215 LYS VAL VAL VAL GLY SER ARG ASN PRO LYS ARG THR ALA SEQRES 6 B 215 ARG LEU PHE PRO SER ALA ALA GLN VAL THR PHE GLN GLU SEQRES 7 B 215 GLU ALA VAL SER SER PRO GLU VAL ILE PHE VAL ALA VAL SEQRES 8 B 215 PHE ARG GLU HIS TYR SER SER LEU CYS SER LEU SER ASP SEQRES 9 B 215 GLN LEU ALA GLY LYS ILE LEU VAL ASP VAL SER ASN PRO SEQRES 10 B 215 THR GLU GLN GLU HIS LEU GLN HIS ARG GLU SER ASN ALA SEQRES 11 B 215 GLU TYR LEU ALA SER LEU PHE PRO THR CYS THR VAL VAL SEQRES 12 B 215 LYS ALA PHE ASN VAL ILE SER ALA TRP THR LEU GLN ALA SEQRES 13 B 215 GLY PRO ARG ASP GLY ASN ARG GLN VAL PRO ILE CYS GLY SEQRES 14 B 215 ASP GLN PRO GLU ALA LYS ARG ALA VAL SER GLU MET ALA SEQRES 15 B 215 LEU ALA MET GLY PHE MET PRO VAL ASP MET GLY SER LEU SEQRES 16 B 215 ALA SER ALA TRP GLU VAL GLU ALA MET PRO LEU ARG LEU SEQRES 17 B 215 LEU PRO ALA TRP LYS VAL PRO HET NAP A 301 48 HET CIT A 302 13 HET NAP B 301 48 HETNAM NAP NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE HETNAM CIT CITRIC ACID HETSYN NAP 2'-MONOPHOSPHOADENOSINE 5'-DIPHOSPHORIBOSE FORMUL 3 NAP 2(C21 H28 N7 O17 P3) FORMUL 4 CIT C6 H8 O7 FORMUL 6 HOH *125(H2 O) HELIX 1 1 GLY A 37 SER A 50 1 14 HELIX 2 2 ASN A 60 ARG A 66 1 7 HELIX 3 3 GLN A 77 VAL A 81 1 5 HELIX 4 4 PHE A 92 TYR A 96 5 5 HELIX 5 5 TYR A 96 SER A 101 5 6 HELIX 6 6 LEU A 102 ALA A 107 1 6 HELIX 7 7 THR A 118 HIS A 125 1 8 HELIX 8 8 SER A 128 PHE A 137 1 10 HELIX 9 9 SER A 150 GLY A 157 1 8 HELIX 10 10 GLN A 171 MET A 185 1 15 HELIX 11 11 SER A 194 ALA A 196 5 3 HELIX 12 12 SER A 197 ALA A 203 1 7 HELIX 13 13 GLY B 37 SER B 50 1 14 HELIX 14 14 ASN B 60 ARG B 66 1 7 HELIX 15 15 GLN B 77 VAL B 81 1 5 HELIX 16 16 PHE B 92 SER B 101 5 10 HELIX 17 17 LEU B 102 ALA B 107 1 6 HELIX 18 18 THR B 118 HIS B 125 1 8 HELIX 19 19 SER B 128 PHE B 137 1 10 HELIX 20 20 SER B 150 GLY B 157 1 8 HELIX 21 21 GLN B 171 MET B 185 1 15 HELIX 22 22 SER B 194 ALA B 196 5 3 HELIX 23 23 SER B 197 ALA B 203 1 7 SHEET 1 AA 8 GLN A 73 PHE A 76 0 SHEET 2 AA 8 VAL A 54 SER A 58 1 O VAL A 54 N GLN A 73 SHEET 3 AA 8 VAL A 31 LEU A 34 1 O VAL A 31 N VAL A 55 SHEET 4 AA 8 VAL A 86 VAL A 89 1 O VAL A 86 N GLY A 32 SHEET 5 AA 8 ILE A 110 ASP A 113 1 O ILE A 110 N ILE A 87 SHEET 6 AA 8 THR A 141 ALA A 145 1 O THR A 141 N LEU A 111 SHEET 7 AA 8 GLN A 164 GLY A 169 -1 O CYS A 168 N LYS A 144 SHEET 8 AA 8 MET A 188 ASP A 191 1 O MET A 188 N VAL A 165 SHEET 1 BA 8 GLN B 73 PHE B 76 0 SHEET 2 BA 8 VAL B 54 SER B 58 1 O VAL B 54 N GLN B 73 SHEET 3 BA 8 VAL B 31 LEU B 34 1 O VAL B 31 N VAL B 55 SHEET 4 BA 8 VAL B 86 VAL B 89 1 O VAL B 86 N GLY B 32 SHEET 5 BA 8 ILE B 110 ASP B 113 1 O ILE B 110 N ILE B 87 SHEET 6 BA 8 THR B 141 ALA B 145 1 O THR B 141 N LEU B 111 SHEET 7 BA 8 GLN B 164 GLY B 169 -1 O CYS B 168 N LYS B 144 SHEET 8 BA 8 MET B 188 ASP B 191 1 O MET B 188 N VAL B 165 CISPEP 1 PRO A 29 LYS A 30 0 -14.72 CISPEP 2 ASP A 160 GLY A 161 0 -9.94 CISPEP 3 PRO B 29 LYS B 30 0 -26.22 CISPEP 4 ARG B 207 LEU B 208 0 -7.70 SITE 1 AC1 24 SER A 36 GLY A 37 ASP A 38 PHE A 39 SITE 2 AC1 24 SER A 58 ARG A 59 ALA A 90 VAL A 91 SITE 3 AC1 24 PHE A 92 HIS A 95 SER A 98 VAL A 114 SITE 4 AC1 24 SER A 115 ASN A 116 ASN A 147 ILE A 149 SITE 5 AC1 24 SER A 150 ALA A 151 HOH A 416 HOH A 436 SITE 6 AC1 24 HOH A 410 HOH A 444 HOH A 401 HOH A 402 SITE 1 AC2 24 GLY B 35 SER B 36 GLY B 37 ASP B 38 SITE 2 AC2 24 PHE B 39 SER B 58 ARG B 59 ALA B 90 SITE 3 AC2 24 VAL B 91 PHE B 92 HIS B 95 SER B 98 SITE 4 AC2 24 VAL B 114 SER B 115 ASN B 116 ILE B 149 SITE 5 AC2 24 ALA B 151 HOH B 402 HOH B 422 HOH B 401 SITE 6 AC2 24 HOH B 429 HOH B 403 HOH B 451 HOH B 443 SITE 1 AC3 3 LYS B 62 ARG B 66 HOH A 427 CRYST1 37.686 66.812 143.366 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.026535 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014967 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006975 0.00000 MTRIX1 1 -1.000000 0.005000 -0.007000 57.10159 1 MTRIX2 1 -0.005000 -0.998000 0.065000 -37.85538 1 MTRIX3 1 -0.007000 0.065000 0.998000 1.41790 1